96 related articles for article (PubMed ID: 21303356)
1. Advances in understanding the pathogenesis of familial thrombocythaemia.
Teofili L; Larocca LM
Br J Haematol; 2011 Mar; 152(6):701-12. PubMed ID: 21303356
[TBL] [Abstract][Full Text] [Related]
2. Hereditary erythrocytosis, thrombocytosis and neutrophilia.
Hong WJ; Gotlib J
Best Pract Res Clin Haematol; 2014 Jun; 27(2):95-106. PubMed ID: 25189721
[TBL] [Abstract][Full Text] [Related]
3. A family with hereditary thrombocythaemia and normal genes for thrombopoietin and c-Mpl.
Tecuceanu N; Dardik R; Rabizadeh E; Raanani P; Inbal A
Br J Haematol; 2006 Nov; 135(3):348-51. PubMed ID: 16995886
[TBL] [Abstract][Full Text] [Related]
4. Genetic origins and clinical phenotype of familial and acquired erythrocytosis and thrombocytosis.
Percy MJ; Rumi E
Am J Hematol; 2009 Jan; 84(1):46-54. PubMed ID: 19006225
[TBL] [Abstract][Full Text] [Related]
5. Familial thrombocytosis caused by the novel germ-line mutation p.Pro106Leu in the MPL gene.
El-Harith el-HA; Roesl C; Ballmaier M; Germeshausen M; Frye-Boukhriss H; von Neuhoff N; Becker C; Nürnberg G; Nürnberg P; Ahmed MA; Hübener J; Schmidtke J; Welte K; Stuhrmann M
Br J Haematol; 2009 Jan; 144(2):185-94. PubMed ID: 19036112
[TBL] [Abstract][Full Text] [Related]
6. MPL mutation profile in JAK2 mutation-negative patients with myeloproliferative disorders.
Ma W; Zhang X; Wang X; Zhang Z; Yeh CH; Uyeji J; Albitar M
Diagn Mol Pathol; 2011 Mar; 20(1):34-9. PubMed ID: 21326037
[TBL] [Abstract][Full Text] [Related]
7. Hereditary thrombocytosis: the genetic landscape.
Han EY; Catherwood M; McMullin MF
Br J Haematol; 2021 Sep; 194(6):1098-1105. PubMed ID: 34341988
[No Abstract] [Full Text] [Related]
8. Molecular pathogenesis of Philadelphia chromosome negative myeloproliferative disorders.
Kralovics R; Skoda RC
Blood Rev; 2005 Jan; 19(1):1-13. PubMed ID: 15572213
[TBL] [Abstract][Full Text] [Related]
9. Clinical course of myeloproliferative leukaemia virus oncogene (MPL) mutation-associated familial thrombocytosis: a review of 64 paediatric and adult patients.
Al-Harbi T; Al-Zahrani M; Al-Balwi M; Al-Hazmi A; Alsuhaibani A; Aljafn N; Alsumari F; Aleshaiwi L; Alsuhibani A; Alqasim O; Ahmad N
Br J Haematol; 2021 Sep; 194(5):893-898. PubMed ID: 34131895
[TBL] [Abstract][Full Text] [Related]
10. Is refractory anaemia with ring sideroblasts and thrombocytosis (RARS-T) a necessary or useful diagnostic category?
Wardrop D; Steensma DP
Br J Haematol; 2009 Mar; 144(6):809-17. PubMed ID: 19120370
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic workflow for hereditary erythrocytosis and thrombocytosis.
McMullin MF
Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):391-396. PubMed ID: 31808840
[TBL] [Abstract][Full Text] [Related]
12. An activating splice donor mutation in the thrombopoietin gene causes hereditary thrombocythaemia.
Wiestner A; Schlemper RJ; van der Maas AP; Skoda RC
Nat Genet; 1998 Jan; 18(1):49-52. PubMed ID: 9425899
[TBL] [Abstract][Full Text] [Related]
13. The activating splice mutation in intron 3 of the thrombopoietin gene is not found in patients with non-familial essential thrombocythaemia.
Harrison CN; Gale RE; Wiestner AC; Skoda RC; Linch DC
Br J Haematol; 1998 Sep; 102(5):1341-3. PubMed ID: 9753068
[TBL] [Abstract][Full Text] [Related]
14. Inherited predisposition to myeloproliferative neoplasms.
Jones AV; Cross NC
Ther Adv Hematol; 2013 Aug; 4(4):237-53. PubMed ID: 23926457
[TBL] [Abstract][Full Text] [Related]
15. A de novo splice donor mutation in the thrombopoietin gene causes hereditary thrombocythemia in a Polish family.
Liu K; Kralovics R; Rudzki Z; Grabowska B; Buser AS; Olcaydu D; Gisslinger H; Tiedt R; Frank P; Okoñ K; van der Maas AP; Skoda RC
Haematologica; 2008 May; 93(5):706-14. PubMed ID: 18367486
[TBL] [Abstract][Full Text] [Related]
16. A case of familial thrombocytosis: possible role of altered thrombopoietin production.
Fujiwara T; Harigae H; Kameoka J; Yokoyama H; Takahashi S; Tomiya Y; Yamada M; Ishizawa K; Imaizumi M; Sasaki T
Am J Hematol; 2004 Aug; 76(4):395-7. PubMed ID: 15282677
[TBL] [Abstract][Full Text] [Related]
17. Advances in the molecular characterization of Philadelphia-negative chronic myeloproliferative disorders.
Pikman Y; Levine RL
Curr Opin Oncol; 2007 Nov; 19(6):628-34. PubMed ID: 17906464
[TBL] [Abstract][Full Text] [Related]
18. Rapid real-time PCR assay for detection of MPL W515L mutation in patients with chronic myeloproliferative disorders.
Ghaderi M; Strömberg O; Porwit A
Int J Lab Hematol; 2010 Feb; 32(1 Pt 2):122-6. PubMed ID: 19016916
[TBL] [Abstract][Full Text] [Related]
19. Janus kinase 2 mutations in Philadelphia negative chronic myeloproliferative disorders: clinical implications.
Panani AD
Cancer Lett; 2009 Oct; 284(1):7-14. PubMed ID: 19269737
[TBL] [Abstract][Full Text] [Related]
20. Unexplained thrombocytosis: association of Baltimore polymorphism with germline MPL nonsense mutation.
Verger E; Teillet F; Conejero C; Letort G; Chomienne C; Giraudier S; Cassinat B
Br J Haematol; 2016 Oct; 175(1):167-9. PubMed ID: 26568271
[No Abstract] [Full Text] [Related]
[Next] [New Search]
